AUG 29, 2015 02:18 PM PDT

Virus Causes Liver Cancer

Viruses can be involved in the development of serious diseases. A case in point is liver cancer, which often develops in an organ that has been weakened by hepatitis B or C virus. 
Liver cancer is usually found in already damaged cells.
Researchers at Inserm, the Paris Public Hospitals (AP-HP), Paris Descartes University, Paris 13 University (USPC) and Paris Diderot University have identified the role of a new virus in a rare type of liver cancer. This study, based on follow-up and observation of 193 patients, is published in Nature Genetics and reported in Drug Discovery & Development

More than 8,000 new individuals are diagnosed with liver cancer every year. It mainly affects men and is a major cause of death worldwide. Of the different types, hepatocellular carcinoma usually occurs in a liver already damaged by illness. The liver may have been weakened by excessive alcohol consumption, obesity or chronic viral infection by hepatitis B or C viruses, causing irreversible liver lesions, ultimately culminating in cirrhosis.

While cirrhosis patients usually undergo regular tests to detect cancer, in 5 percent of cases, liver cancer occurs in patients who had not reported cirrhosis. Thus, the reason for developing the cancer is a mystery. Jessica Zucman-Rossi and her staff at Inserm Unit 1162, Functional Genomics of Solid Tumors, took a special interest in these patients to discover the risk factors that had contributed to the development of their cancer.

According to the report, “In the genome of tumor cells of 11 patients, the scientists observed the insertion of a viral DNA segment from adeno-associated virus type 2, known as AAV2. This virus has been considered non-pathogenic for humans until now. In order to confirm the virus's involvement in the cancer, the research team compared tumor tissues with normal tissues. They thus confirmed their hypothesis: the integration of viral DNA was found more often in tumor cells than in healthy cells in these 11 patients. Moreover, eight of these patients did not have cirrhosis, and six of them presented no known risk factors for liver cancer.

When they studied these malignant cells in greater detail, the researchers discovered that the virus, when putting its DNA into the genome of the patient's cells, targets genes important in cell proliferation. The researchers have demonstrated that AAV2 leads to excessive expression of these genes that may cause tumor development.

In this work, the researchers have identified the involvement of AAV2 virus, which used to be considered harmless, in the occurrence of hepatocellular carcinoma, especially in the rare cases of cancer that develop without cirrhosis or another identified cause. The researchers caution, "AAV2 is often used as a vector in gene therapy. Although the insertion of its DNA into tumor promoting genes is rare, and probably a chance event, precautions must be taken regarding the use of this virus."
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
AUG 21, 2018
Cancer
AUG 21, 2018
'Zombie' gene returns to life and kills cancer in elephants
Researchers have discovered a gene that can protect elephants from cancer. An estimated 17 percent of humans worldwide die from cancer, but less than five ...
OCT 17, 2018
Cell & Molecular Biology
OCT 17, 2018
Saving Patients From Unnecessary Chemotherapy with a Blood Test
Often, cancer patients get chemotherapy after surgery to ensure that their cancer will not come back; for many it's not needed....
OCT 29, 2018
Neuroscience
OCT 29, 2018
Gut: a second brain and novel therapeutic target
Undersatnding the role of gut microbiome in disease pathologies and targetting them for potential treatment strategies....
NOV 12, 2018
Cancer
NOV 12, 2018
Targeted radiation therapy may provide new hope to children with difficult-to-treat liver cancer
Primary malignant liver tumors are rare in children with an occurrence rate of 1-2% of all childhood cancers. Radical surgical resection of the liver which means the removal of part of the li...
NOV 14, 2018
Immunology
NOV 14, 2018
Rapid Tumor Targeting
Researchers at the University of California Irvine have developed a technology that will rapidly identify and target T cell receptors for tumor specific antigens...
NOV 26, 2018
Cell & Molecular Biology
NOV 26, 2018
New Insight Into the Machinery That Drives Cell Death
When cells are worn out and damaged or diseased, they can initiate a self-destruct sequence called apoptosis....
Loading Comments...